Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-21.89 Mil
% of Total Estimate Gain
-77.60%

Lynx1 Capital Management LP's Keros Therapeutics Inc Holding Summary

As of 2025-03-31, Lynx1 Capital Management LP held - shares of Keros Therapeutics Inc(KROS), totaling N/A. This investment constitutes 0% of their stock portfolio, and Lynx1 Capital Management LP now holds 0% of the outstanding Keros Therapeutics Inc(KROS) stock.

The initial trade took place in 2024Q4. And since then Lynx1 Capital Management LP has made 1 purchases of KROS, at an average price of $51.84, for a total of 544,001.00 shares. In addition, there have been 1 sales at an average price of $11.61 for 544,001.00 shares. Based on historical transaction data and KROS's current price of $14.43, Lynx1 Capital Management LP's estimated gain on his KROS holdings is $-21.89 Mil, reflecting a -77.60% gain to date.

Lynx1 Capital Management LP KROS ($14.43) Holding Chart

Lynx1 Capital Management LP KROS ($14.43) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1